New Delhi: With US President Donald Trump who requested Prime Minister Narendra Modi to supply hydroxychloroquine tablets for the utilisation to treat COVID-19 patients, it is reported that several other leaders have approached PM Modi for the supply of medicine.
“I called Prime Minister Modi of India this morning. They make large amounts of Hydroxychloroquine. India is giving it serious consideration,” Trump said at his daily news conference at the White House on Saturday.
PM Modi after a discussion with Brazilian President Jair Bolsonaro over COVID-19, the latter tweeted in Portuguese about the discussion, saying he requested India for support in the continuity of the supply of pharmaceutical inputs for the production of hydroxychloroquine.
Neste sábado, em contato com o Primeiro-Ministro da Índia, @narendramodi , solicitei apoio na continuidade do fornecimento de insumos farmacêuticos para a produção da hidroxicloroquina. Não mediremos esforços para salvar vidas. 🇧🇷🤝🇮🇳 pic.twitter.com/v03Bvti40R
— Jair M. Bolsonaro (@jairbolsonaro) April 4, 2020
According to reports, SAARC members, Indonesia and the UAE have requested India to revoke the ban on export of hydroxychloroquine, as they see a shortage of the drug primarily used for rheumatoid arthritis and long-term autoimmune disease lupus.
As per reports, several other European countries have also requested India for the supply of hydroxychloroquine.
On March 25, India’s Directorate General of Foreign Trade imposed a ban on the export of the medicine.
“Hydroxychloroquine is found to be effective against coronavirus in laboratory studies and in-vivo studies. Its use in prophylaxis is derived from the available evidence of benefit as treatment and supported by preclinical data,” said Drug Controller General of India’s (DGCI) advisory.
